Efficacy News and Research

RSS
New research focuses on perfectionism to improve treatment for adolescent anorexia

New research focuses on perfectionism to improve treatment for adolescent anorexia

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Results from Phase II START study published in The Lancet Diabetes & Endocrinology

Results from Phase II START study published in The Lancet Diabetes & Endocrinology

USF professor studies ethics of RCT and efficacy in outcomes of new treatments

USF professor studies ethics of RCT and efficacy in outcomes of new treatments

HCV treatment with sofosbuvir and ribavirin results in sustained virologic response

HCV treatment with sofosbuvir and ribavirin results in sustained virologic response

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

New tool may make surgery more viable option for OSAHS sufferers

New tool may make surgery more viable option for OSAHS sufferers

Lipidor announces positive results from Phase I/IIa study of AKVANO/calcipotriol for psoriasis vulgaris

Lipidor announces positive results from Phase I/IIa study of AKVANO/calcipotriol for psoriasis vulgaris

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Study: Early stuttering not linked to development issues

Study: Early stuttering not linked to development issues

Researchers develop therapeutic algorithm to study outcomes in epistaxis management

Researchers develop therapeutic algorithm to study outcomes in epistaxis management

Mount Sinai scientists receive NIH grant to study clinical benefit of IGF-1 in children with PMS

Mount Sinai scientists receive NIH grant to study clinical benefit of IGF-1 in children with PMS

Sanofi Pasteur reports clinical benefit of Fluzone High-Dose vaccine in preventing influenza

Sanofi Pasteur reports clinical benefit of Fluzone High-Dose vaccine in preventing influenza

Sangamo BioSciences signs definitive agreement to buy Ceregene

Sangamo BioSciences signs definitive agreement to buy Ceregene

Immune Pharmaceuticals announces completion of merger with EpiCept Corporation

Immune Pharmaceuticals announces completion of merger with EpiCept Corporation

Scientists receive NIH grant to study commercially-available drug for treatment of PMS

Scientists receive NIH grant to study commercially-available drug for treatment of PMS

Scanning technique reveals how brain tumor responds to drug administered

Scanning technique reveals how brain tumor responds to drug administered

Stem cell therapy improves radiation-induced cognitive impairment

Stem cell therapy improves radiation-induced cognitive impairment

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.